Dendritic cells star in Vancouver

Por Klechevsky, Eynav, Kato, Hiroki, Sponaas, Anne-Marit
Publicado em 2005

Transient Deficiency of Dendritic Cells Results in Lack of a Merozoite Surface Protein 1-Specific CD4 T Cell Response during Peak Plasmodium chabaudi Blood-Stage Infection

Por Sponaas, Anne-Marit, Belyaev, Nikolai, Falck-Hansen, Mika, Potocnik, Alexandre, Langhorne, Jean
Publicado em 2012

gp96-Peptide Vaccination of Mice against Intracellular Bacteria

Por Zügel, Ulrich, Sponaas, Anne-Marit, Neckermann, Jutta, Schoel, Bernd, Kaufmann, Stefan H. E.
Publicado em 2001

Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer

Por Tøndell, Anders, Wahl, Sissel Gyrid Freim, Sponaas, Anne-Marit, Sørhaug, Sveinung, Børset, Magne, Haug, Markus
Publicado no Transl Oncol (2019)

Differential Requirement for Cathepsin D for Processing of the Full Length and C-Terminal Fragment of the Malaria Antigen MSP1

Por Tulone, Calogero, Sponaas, Anne-Marit, Raiber, Eun-Ang, Tabor, Alethea B., Langhorne, Jean, Chain, Benny M.
Publicado em 2011

Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific T cells

Por Sponaas, Anne-Marit, Cadman, Emma Tamsin, Voisine, Cecile, Harrison, Vicky, Boonstra, Andre, O'Garra, Anne, Langhorne, Jean
Publicado em 2006

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy

Por Sponaas, Anne-Marit, Moharrami, Neda Nejati, Feyzi, Emadoldin, Standal, Therese, Holth Rustad, Even, Waage, Anders, Sundan, Anders
Publicado no PLoS One (2015)

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?

Por Sponaas, Anne Marit, Waage, Anders, Vandsemb, Esten N., Misund, Kristine, Børset, Magne, Sundan, Anders, Slørdahl, Tobias Schmidt, Standal, Therese
Publicado no Front Immunol (2021)

Alterations of Splenic Architecture in Malaria Are Induced Independently of Toll-Like Receptors 2, 4, and 9 or MyD88 and May Affect Antibody Affinity

Por Cadman, Emma T., Abdallah, Asmahan Y., Voisine, Cécile, Sponaas, Anne-Marit, Corran, Patrick, Lamb, Tracey, Brown, Douglas, Ndungu, Francis, Langhorne, Jean
Publicado em 2008

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro

Por Våtsveen, Thea Kristin, Sponaas, Anne-Marit, Tian, Erming, Zhang, Qing, Misund, Kristine, Sundan, Anders, Børset, Magne, Waage, Anders, Brede, Gaute
Publicado no J Hematol Oncol (2016)

IL-22 Protects Against Liver Pathology and Lethality of an Experimental Blood-Stage Malaria Infection

Por Mastelic, Béatris, do Rosario, Ana Paula Freitas, Veldhoen, Marc, Renauld, Jean Christophe, Jarra, William, Sponaas, Anne-Marit, Roetynck, Sophie, Stockinger, Brigitta, Langhorne, Jean
Publicado em 2012

Targeting phosphoglycerate dehydrogenase in multiple myeloma

Por Elsaadi, Samah, Steiro, Ida, Abdollahi, Pegah, Vandsemb, Esten N., Yang, Rui, Slørdahl, Tobias S., Rø, Torstein Baade, Menu, Eline, Sponaas, Anne-Marit, Børset, Magne
Publicado no Exp Hematol Oncol (2021)

Caspase‐8 regulates the expression of pro‐ and anti‐inflammatory cytokines in human bone marrow‐derived mesenchymal stromal cells

Por Moen, Siv H., Westhrin, Marita, Zahoor, Muhammad, Nørgaard, Nikolai N., Hella, Hanne, Størdal, Berit, Sundan, Anders, Nilsen, Nadra J., Sponaas, Anne‐Marit, Standal, Therese
Publicado no Immun Inflamm Dis (2016)

PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients

Por Sponaas, Anne-Marit, Yang, Rui, Rustad, Even Holth, Standal, Therese, Thoresen, Aud Solvang, Dao Vo, Camilla, Waage, Anders, Slørdahl, Tobias S., Børset, Magne, Sundan, Anders
Publicado no Oncotarget (2018)

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss

Por Zahoor, Muhammad, Westhrin, Marita, Aass, Kristin Roseth, Moen, Siv Helen, Misund, Kristine, Psonka-Antonczyk, Katarzyna Maria, Giliberto, Mariaserena, Buene, Glenn, Sundan, Anders, Waage, Anders, Sponaas, Anne-Marit, Standal, Therese
Publicado no Blood Adv (2017)

Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone

Por Westhrin, Marita, Holien, Toril, Zahoor, Muhammad, Moen, Siv Helen, Buene, Glenn, Størdal, Berit, Hella, Hanne, Yuan, Huipin, de Bruijn, Joost D, Martens, Anton, Groen, Richard WJ, Bosch, Fatima, Smith, Ulf, Sponaas, Anne‐Marit, Sundan, Anders, Standal, Therese
Publicado no JBMR Plus (2019)

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade

Por Yang, Rui, Elsaadi, Samah, Misund, Kristine, Abdollahi, Pegah, Vandsemb, Esten Nymoen, Moen, Siv Helen, Kusnierczyk, Anna, Slupphaug, Geir, Standal, Therese, Waage, Anders, Slørdahl, Tobias S, Rø, Torstein Baade, Rustad, Even, Sundan, Anders, Hay, Carl, Cooper, Zachary, Schuller, Alwin G, Woessner, Richard, Borodovsky, Alexandra, Menu, Eline, Børset, Magne, Sponaas, Anne Marit
Publicado no J Immunother Cancer (2020)